Eric Flackbart
<span data-metadata=""><span data-buffer="">VP Regulatory Affairs
Eric joined Byonyks, Inc. as Vice President Regulatory Affairs in January 2022.
Eric’s invaluable expertise in medical device development has yielded remarkable contributions to the field. With an impressive 30-year history, he has consistently pioneered inventive solutions that streamline the crucial process of fluid management in patient care.
With wide-ranging expertise, he has made significant strides in the realm of medical devices, spanning various areas. This includes the development of infusion pumps tailored for diverse applications, as well as pioneering a proof-of-concept amputated limb perfusion machine for the US military. His accomplishments extend from inventing cutting-edge technologies like the FDA-cleared first smart infusion pump with a downloadable drug library to establishing robust company infrastructure for the development and commercialization of medical devices within the United States.
In 2018, Eric embarked on a mission-driven journey named Byonyks, aiming to introduce a user-friendly and portable Bloodles Dialysis Cycler across the globe. Recognizing the immense importance of this endeavor, he wholeheartedly dedicated himself to the project, which is now well underway. Demonstrating unwavering dedication, Eric made the decision to relocate to Lahore, Pakistan, ensuring the successful completion of the development phase and securing regulatory clearance across multiple market areas.Throughout his illustrious career, Eric actively contributed to the development of an impressive portfolio of 39 distinct medical devices, showcasing his versatility and proficiency in driving meaningful innovation.At Byonyks, Eric’s profound experience and unwavering determination make him an invaluable asset to the team. His expertise and guidance will undoubtedly play a pivotal role in bringing peritoneal dialysis to Pakistan and other countries, significantly improving the lives of numerous individuals in need of this critical medical intervention.